Brunner Syndrome
|
0.910 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
New insights into Brunner syndrome and potential for targeted therapy.
|
25807999 |
2016 |
Brunner Syndrome
|
0.910 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The International Working Group on Neurotransmitter related Disorders (iNTD): A worldwide research project focused on primary and secondary neurotransmitter disorders.
|
27830117 |
2016 |
Brunner Syndrome
|
0.910 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
It is the case of the X-linked gene encoding monoamine oxidase A (MAOA), for which only one nonsense mutation has been identified in Brunner syndrome, characterized in a single family by mild non-dysmorphic ID and impulsive, violent and aggressive behaviors.
|
24169519 |
2014 |
Brunner Syndrome
|
0.910 |
GeneticVariation
|
disease |
BEFREE |
It is the case of the X-linked gene encoding monoamine oxidase A (MAOA), for which only one nonsense mutation has been identified in Brunner syndrome, characterized in a single family by mild non-dysmorphic ID and impulsive, violent and aggressive behaviors.
|
24169519 |
2014 |
Brunner Syndrome
|
0.910 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
It is the case of the X-linked gene encoding monoamine oxidase A (MAOA), for which only one nonsense mutation has been identified in Brunner syndrome, characterized in a single family by mild non-dysmorphic ID and impulsive, violent and aggressive behaviors.
|
24169519 |
2014 |
Brunner Syndrome
|
0.910 |
GermlineCausalMutation
|
disease |
ORPHANET |
It is the case of the X-linked gene encoding monoamine oxidase A (MAOA), for which only one nonsense mutation has been identified in Brunner syndrome, characterized in a single family by mild non-dysmorphic ID and impulsive, violent and aggressive behaviors.
|
24169519 |
2014 |
Brunner Syndrome
|
0.910 |
Biomarker
|
disease |
MGD |
This mutation is analogous to the cause of a rare human disorder, Brunner syndrome, characterized by complete MAO A deficiency and impulsive aggressiveness.
|
18418249 |
2008 |
Brunner Syndrome
|
0.910 |
Biomarker
|
disease |
MGD |
Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA.
|
7792602 |
1995 |
Brunner Syndrome
|
0.910 |
GermlineCausalMutation
|
disease |
ORPHANET |
Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A.
|
8211186 |
1993 |
Brunner Syndrome
|
0.910 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Brunner Syndrome
|
0.910 |
Biomarker
|
disease |
CTD_human |
|
|
|
Brunner Syndrome
|
0.910 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Autistic Disorder
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Moreover, reduced MAOA expression may play a role in the mechanistic pathway linking SSRI exposure and behavioral deficits symptomatic of autism.
|
31170382 |
2020 |
Autistic Disorder
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
These results suggest impaired MAO-A activity in the brain of subjects with autism, especially in children with autism.
|
28151561 |
2017 |
Autistic Disorder
|
0.500 |
Biomarker
|
disease |
BEFREE |
Interaction between MAOA and FOXP2 in association with autism and verbal communication in a Korean population.
|
24356376 |
2014 |
Autistic Disorder
|
0.500 |
Biomarker
|
disease |
CTD_human |
We replicated and extended a previously reported association between autism severity and a functional polymorphism in the monoamine oxidase A (MAOA) promoter region, MAOA-uVNTR, in a sample of 119 males, aged 2-13 years, with autism spectrum disorder from simplex families.
|
20573161 |
2011 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
However, the male children carrying 4 tandem repeats in the promoter region of the MAOA gene showed a two-fold higher risk of AU (or AU+ASD) than those carrying allele 3, adjusted for confounders (OR = 2.02, 95% CI = 1.12, 3.65, P = 0.02 for AU vs. TD, and OR = 2.05, 95% CI = 1.19, 3.53, P = 0.01 for ASD vs. TD).
|
21538940 |
2011 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We replicated and extended a previously reported association between autism severity and a functional polymorphism in the monoamine oxidase A (MAOA) promoter region, MAOA-uVNTR, in a sample of 119 males, aged 2-13 years, with autism spectrum disorder from simplex families.
|
20573161 |
2011 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In this study we genotyped the MAOA promoter polymorphism in a group of 29 males (age 2-3 years) with autism and a group of 39 healthy pediatric controls for whom brain MRI data was available.
|
18361446 |
2008 |
Autistic Disorder
|
0.500 |
Biomarker
|
disease |
CTD_human |
In this study we genotyped the MAOA promoter polymorphism in a group of 29 males (age 2-3 years) with autism and a group of 39 healthy pediatric controls for whom brain MRI data was available.
|
18361446 |
2008 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Modifier effects in autism at the MAO-A and DBH loci.
|
15048649 |
2004 |
Autistic Disorder
|
0.500 |
Biomarker
|
disease |
CTD_human |
We conclude that functional MAOA-uVNTR alleles may act as a genetic modifier of the severity of autism in males.
|
12919132 |
2003 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We conclude that functional MAOA-uVNTR alleles may act as a genetic modifier of the severity of autism in males.
|
12919132 |
2003 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In the current study, we therefore examined, using the robust transmission disequilibrium test (TDT), possible preferential transmission of variants of a functional monoamine oxidase A (MAO A) promoter region polymorphism for linkage to autism.
|
11920849 |
2002 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Negative results for transmission disequilibrium of polymorphisms of HTR2C and MAOA with autism were provided from German and Austrian families.
|
10374746 |
1999 |